MedPath

Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study.

Completed
Conditions
Bile Reflux Gastritis
Precancerous Lesions
Intestinal Metaplasia
Gastric Cancer
Helicobacter Pylori Infection
Registration Number
NCT03976739
Lead Sponsor
Xijing Hospital of Digestive Diseases
Brief Summary

To explore the effects of bile reflux on gastric cancer and its precancerous lesions, so as to better prevent the occurrence and development of gastric cancer.

Detailed Description

This study was a multicenter cross-sectional study. Patients were consecutively enrolled and divided into gastric cancer group, gastric precancerous lesions group, and chronic gastritis group, according to histopathological results. The bile reflux detection rate and Helicobacter pylori infection status were recorded for each group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1162
Inclusion Criteria
  1. Age 18 to 75 years old, gender is not limited;
  2. patients with upper abdominal pain, abdominal distension, belching, anorexia, early satiety, hiccup, acid reflux, upper abdomen burning sensation and other upper gastrointestinal symptoms;
  3. Voluntary acceptance of Hp testing;
  4. Voluntary acceptance of the endoscopy and pathological biopsy.
Exclusion Criteria
  1. had undergone upper gastrointestinal surgery;
  2. Previous diagnosis of esophageal cancer;
  3. Previous diagnosis of gastric cancer;
  4. Previous diagnosis of MALT lymphoma;
  5. pregnant and lactating women;
  6. Those with mental disorders;
  7. Refusal to sign the informed consent form.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
corelation between the bile reflux and gastric mucosa diseasesup to 6 months

we evaluate the corelation between the bile reflux and gastric mucosa diseases according to the histopathological results and the scales the patients finished

Secondary Outcome Measures
NameTimeMethod
the risk factors of primary bile reflux gastritisup to 6 months

we evaluate the the risk factors of primary bile reflux gastritis according to the scales and endoscopical results

Trial Locations

Locations (1)

Xijing Hosipital of Digestive Disease

🇨🇳

Xi'an, Shaanxi, China

© Copyright 2025. All Rights Reserved by MedPath